The global healthcare IT consulting market size reached US$ 34.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 97.45 Billion by 2027, exhibiting a growth rate (CAGR) of 17.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Healthcare IT consulting services refer to advisory support provided regarding financial planning, operations management, and business decisions to healthcare organizations and professionals. They are widely used to analyze business needs, workflows, and security, review IT environment components, improve patient care and healthcare procedures, and enhance information tracking and reporting systems. Healthcare IT consulting aids in minimizing medical malpractice, increasing telehealth opportunities, remaining compliant with data privacy laws, understanding organization, and offering faster service to patients. As a result, these services are employed by healthcare payers, providers, hospitals, imaging and diagnostic centers, and public health entities. Healthcare IT Consulting Market Trends: Growing digitization in the healthcare industry across the globe is creating a positive outlook for the market. Healthcare IT consulting helps in the development and maintenance of clinical platforms, analytics dashboard, network optimization services, revenue cycle management (RCM), and enterprise resource planning support services. In line with this, the rising number of hospital admissions has surged the demand for advanced and efficient systems to cope with growing healthcare processes and infrastructure, which, in turn, is favoring the market growth. Apart from this, the integration of artificial intelligence (AI) with healthcare IT consulting services to ensure data privacy, optimize resource management, gain insights from unstructured data, and provide a modernized approach to decision-making processes is providing an impetus to the market growth. Furthermore, the increasing need for data security and the widespread adoption of digital healthcare models over paper-based counterparts is positively impacting the market growth. Other factors, including the implementation of various government initiatives supporting healthcare IT solutions, the rising geriatric population, extensive research and development (R&D) activities, and the growing adoption of electronic record maintenance, are propelling the market growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global healthcare IT consulting market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on consulting type and end user. Breakup by Consulting Type: HCIT Change Management Healthcare Business Process Management HCIT Integration and Migration Healthcare/Medical System Security Set-Up and Risk Assessment Healthcare Enterprise Reporting and Data Analytics Others Breakup by End User: Hospitals and Ambulatory Care Centers Diagnostic and Imaging Centers Public and Private Payers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture plc, Atos SE, Deloitte Touche Tohmatsu Limited, Genpact, HCL Technologies Limited (HCL Enterprise), Infosys Limited, International Business Machines Corporation, Koninklijke Philips N.V., NTT DATA Corporation (Nippon Telegraph and Telephone Corporation), Oracle Corporation, Siemens Healthineers AG (Siemens AG) and Tata Consultancy Services Limited. Key Questions Answered in This Report: How has the global healthcare IT consulting market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global healthcare IT consulting market? What are the key regional markets? What is the breakup of the market based on the consulting type? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global healthcare IT consulting market and who are the key players? What is the degree of competition in the industry?

1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Healthcare IT Consulting Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Consulting Type 6.1 HCIT Change Management 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Healthcare Business Process Management 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 HCIT Integration and Migration 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Healthcare/Medical System Security Set-Up and Risk Assessment 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Healthcare Enterprise Reporting and Data Analytics 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Others 6.6.1 Market Trends 6.6.2 Market Forecast 7 Market Breakup by End User 7.1 Hospitals and Ambulatory Care Centers 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Diagnostic and Imaging Centers 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Public and Private Payers 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Others 7.4.1 Market Trends 7.4.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Accenture plc 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 Atos SE 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.2.4 SWOT Analysis 13.3.3 Deloitte Touche Tohmatsu Limited 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 SWOT Analysis 13.3.4 Genpact 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.5 HCL Technologies Limited (HCL Enterprise) 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.5.3 Financials 13.3.5.4 SWOT Analysis 13.3.6 Infosys Limited 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.6.3 Financials 13.3.6.4 SWOT Analysis 13.3.7 International Business Machines Corporation 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.7.3 Financials 13.3.7.4 SWOT Analysis 13.3.8 Koninklijke Philips N.V 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.8.3 Financials 13.3.8.4 SWOT Analysis 13.3.9 NTT DATA Corporation (Nippon Telegraph and Telephone Corporation) 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.9.3 Financials 13.3.9.4 SWOT Analysis 13.3.10 Oracle Corporation 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.10.3 Financials 13.3.10.4 SWOT Analysis 13.3.11 Siemens Healthineers AG (Siemens AG) 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio 13.3.11.3 Financials 13.3.11.4 SWOT Analysis 13.3.12 Tata Consultancy Services Limited 13.3.12.1 Company Overview 13.3.12.2 Product Portfolio 13.3.12.3 Financials 13.3.12.4 SWOT Analysis